Na Li

3.2k total citations
136 papers, 2.4k citations indexed

About

Na Li is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Na Li has authored 136 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 21 papers in Cardiology and Cardiovascular Medicine and 21 papers in Genetics. Recurrent topics in Na Li's work include Wnt/β-catenin signaling in development and cancer (7 papers), Virus-based gene therapy research (7 papers) and S100 Proteins and Annexins (7 papers). Na Li is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (7 papers), Virus-based gene therapy research (7 papers) and S100 Proteins and Annexins (7 papers). Na Li collaborates with scholars based in China, United States and Japan. Na Li's co-authors include Wei Chen, Amit Saxena, Vikrant Rai, Nikolaos G. Frangogiannis, Ya Su, Tamara J. Phillips, Yingxi Xu, Si Chen, Rong Xiang and Yanan Chen and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Na Li

122 papers receiving 2.4k citations

Peers

Na Li
Nadira Yuldasheva United Kingdom
Eric Larsen United States
Regina M. Day United States
Nadira Yuldasheva United Kingdom
Na Li
Citations per year, relative to Na Li Na Li (= 1×) peers Nadira Yuldasheva

Countries citing papers authored by Na Li

Since Specialization
Citations

This map shows the geographic impact of Na Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Li more than expected).

Fields of papers citing papers by Na Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Li. The network helps show where Na Li may publish in the future.

Co-authorship network of co-authors of Na Li

This figure shows the co-authorship network connecting the top 25 collaborators of Na Li. A scholar is included among the top collaborators of Na Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Li. Na Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuhan, Nannan Han, Tong Shi, et al.. (2025). Mechanisms and applications of mesenchymal stem cell exosomes in enhancing fertility. Stem Cell Research & Therapy. 16(1). 588–588.
2.
Li, Hao, Junhee Han, Yawei Xu, et al.. (2025). Klf9 promotes the repair of myocardial infarction by regulating macrophage recruitment and polarization. JCI Insight. 10(9). 1 indexed citations
4.
Li, Yanhua, et al.. (2025). Doxorubicin prodrug for γ-glutamyl transpeptidase imaging and on-demand cancer therapy. Biosensors and Bioelectronics. 272. 117127–117127. 1 indexed citations
5.
10.
Liu, Xianyang, Qian Zhou, Ruonan Li, et al.. (2024). Autophagy‐mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization. SHILAP Revista de lepidopterología. 5(8). e668–e668. 2 indexed citations
11.
Li, Na, et al.. (2024). Safety, pharmacokinetics, and pharmacodynamics of anti‐IL‐4Rα antibody SHR‐1819 in healthy subjects: A randomized, controlled phase I study. Clinical and Translational Science. 17(4). e13763–e13763. 2 indexed citations
13.
Li, Na, et al.. (2023). Correlation of Obesity and Clinical Characteristics in Drug-Naive First-Episode Patients With Schizophrenia. Clinical Neuropharmacology. 46(5). 186–191.
14.
Hong, Lingjuan, Na Li, Victor Gasque, et al.. (2022). Prdm6 controls heart development by regulating neural crest cell differentiation and migration. JCI Insight. 7(4). 16 indexed citations
15.
Fu, Zhe, Linjie Zhang, Shi‐Yi Wang, et al.. (2022). Synthesis of Coumarin Derivatives: A New Class of Coumarin-Based G Protein-Coupled Receptor Activators and Inhibitors. Polymers. 14(10). 2021–2021. 9 indexed citations
16.
Kamp, Kimberly, Na Li, Daniel M. Lachance, et al.. (2022). Interpersonal Variability in Gut Microbial Calprotectin Metabolism. SHILAP Revista de lepidopterología. 1(5). 853–856. 3 indexed citations
17.
Xie, Fei, Zhaoyang Wang, Bin Liu, et al.. (2021). ILF3 is responsible for hyperlipidemia-induced arteriosclerotic calcification by mediating BMP2 and STAT1 transcription. Journal of Molecular and Cellular Cardiology. 161. 39–52. 15 indexed citations
18.
19.
Hu, Jing, et al.. (2013). An analysis of clinical features and pathology in 40 patients with dysferlinopathy. Chin J Neurol. 46(7). 438–442. 1 indexed citations
20.
Xiu, Yan, Kazuhiro Nakamura, Masaaki Abe, et al.. (2002). Transcriptional Regulation of Fcgr2b Gene by Polymorphic Promoter Region and Its Contribution to Humoral Immune Responses. The Journal of Immunology. 169(8). 4340–4346. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026